| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |